Golden
Codiak BioSciences

Codiak BioSciences

Codiak Biosciences is a biotechnology company developing exosome therapeutics.

Codiak Biosciences is a biotechnology company developing exosome therapeutics that is headquartered in Cambridge, Massachusetts and was founded by Eric lander and Raghu Kalluri in 2015.

Funding

Series A

On November 17, 2015 Codiak BioSciences completed their series A funding round with $31 million in capital from Flagship Pioneering, ARCH Venture Partners, and Fidelity Management and Research Company. 

Series B

On January 26, 2016 Codiak BioSciences completed their series B funding round with $61 million in capital from Flagship Pioneering (lead investor), ARCH Venture Partners (lead investor), Alexandria Venture, and Alaska Permanent Fund. 

Series C

On November 27, 2017 Codiak BioSciences completed their series C funding round with $76.5 million in capital from Sirona Capital, Qatar Investment Authority, Flagship Pioneering, Fidelity Management and Research Company. 



Timeline

November 27, 2017

Series C funding round

On November 27, 2017 Codiak BioSciences completed their series C funding round with $76.5 million in capital from Sirona Capital, Qatar Investment Authority, Flagship Pioneering, Fidelity Management and Research Company. 

January 26, 2016

Series B funding round

On January 26, 2016 Codiak BioSciences completed their series B funding round with $61 million in capital from Flagship Pioneering (lead investor), ARCH Venture Partners (lead investor), Alexandria Venture, and Alaska Permanent Fund. 

November 17, 2015

Series A funding round

On November 17, 2015 Codiak BioSciences completed their series A funding round with $31 million in capital from Flagship Pioneering, ARCH Venture Partners, and Fidelity Management and Research Company. 

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date

Codiak BioSciences Presents First Data on exoSTING - A Novel Engineered Exosome Therapeutic Targeting Checkpoint Refractory Tumors at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

Codiak BioSciences, Inc.

Web



What You Need to Know About Codiak BioSciences

Mark Terry

Web



Xconomy: VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M

Ben Fidler

Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References